1. Home
  2. VSTA vs GOSS Comparison

VSTA vs GOSS Comparison

Compare VSTA & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTA
  • GOSS
  • Stock Information
  • Founded
  • VSTA 1966
  • GOSS 2015
  • Country
  • VSTA Brazil
  • GOSS United States
  • Employees
  • VSTA N/A
  • GOSS N/A
  • Industry
  • VSTA Other Consumer Services
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSTA Real Estate
  • GOSS Health Care
  • Exchange
  • VSTA Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • VSTA 257.4M
  • GOSS 212.8M
  • IPO Year
  • VSTA 2020
  • GOSS 2019
  • Fundamental
  • Price
  • VSTA $4.42
  • GOSS $1.17
  • Analyst Decision
  • VSTA Sell
  • GOSS Strong Buy
  • Analyst Count
  • VSTA 2
  • GOSS 5
  • Target Price
  • VSTA $3.00
  • GOSS $9.20
  • AVG Volume (30 Days)
  • VSTA 26.3K
  • GOSS 1.5M
  • Earning Date
  • VSTA 03-12-2025
  • GOSS 03-13-2025
  • Dividend Yield
  • VSTA N/A
  • GOSS N/A
  • EPS Growth
  • VSTA N/A
  • GOSS N/A
  • EPS
  • VSTA 0.98
  • GOSS N/A
  • Revenue
  • VSTA $270,690,068.00
  • GOSS $114,701,000.00
  • Revenue This Year
  • VSTA $10.26
  • GOSS N/A
  • Revenue Next Year
  • VSTA $11.92
  • GOSS $154.71
  • P/E Ratio
  • VSTA $4.44
  • GOSS N/A
  • Revenue Growth
  • VSTA 12.64
  • GOSS N/A
  • 52 Week Low
  • VSTA $1.60
  • GOSS $0.50
  • 52 Week High
  • VSTA $4.50
  • GOSS $1.55
  • Technical
  • Relative Strength Index (RSI)
  • VSTA 81.68
  • GOSS 44.02
  • Support Level
  • VSTA $3.37
  • GOSS $1.10
  • Resistance Level
  • VSTA $3.58
  • GOSS $1.48
  • Average True Range (ATR)
  • VSTA 0.24
  • GOSS 0.11
  • MACD
  • VSTA 0.09
  • GOSS -0.03
  • Stochastic Oscillator
  • VSTA 93.26
  • GOSS 11.46

About VSTA Vasta Platform Limited

Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: